4.480USD+0.22%Mkt Cap: 316.62M $P/E: —Today
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The c…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap316.62M $
Enterprise Value3.79M $
Revenue (TTM)510.36K $
Gross Profit167.41K $
Net Income (TTM)-8.31M $
Revenue/Share0.4660 USD
Last Price4.480 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.79
EV/Revenue7.43
P/S664.21
P/B1.05
EPS (TTM)-0.13
EPS (Forward)—
52W Range
1.70012% of range25.00
52W High25.00 USD
52W Low1.700 USD
Profitability
Gross Margin28.05%
Oper. Margin-444.59%
EBITDA Margin-265.93%
Profit Margin-1392.61%
ROE291.05%
ROA-60.32%
Growth
Revenue Growth95.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M $
CapEx (TTM)1.44M $
FCF Margin-759.38%
FCF Yield-1.22%
Net Debt-3.11M $
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity-0.00
Current Ratio13.18
Quick Ratio12.91
Book Value/Sh4.571 USD
Cash/Share2.173 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.70.83M
Float319.74K
Insiders80.13%
Institutions0.40%
Short Interest
Short Ratio0.1d
Short % Float0.10%
Short % Out.0.02%
Shares Short16.27K
Short (prev mo.)11.17K
Technical
SMA 502.562 (+74.9%)
SMA 2007.103 (-36.9%)
Beta-0.13
S&P 52W Chg18.16%
Avg Vol (30d)45.88K
Avg Vol (10d)53.68K
Technical Indicators
RSI (14)80.2
MACD0.2489
MACD Signal0.0389
MACD Hist.+0.2100
BB Upper3.627 USD
BB Middle2.521 USD
BB Lower1.414 USD
BB Width87.81%
ATR (14)0.4233 USD
Vol Ratio (20d)2.26x